|
Name |
(Z)-p-Menth-2-en-1-ol
|
Molecular Formula | C10H18O | |
IUPAC Name* |
(1S,4S)-1-methyl-4-propan-2-ylcyclohex-2-en-1-ol
|
|
SMILES |
CC(C)[C@@H]1CC[C@](C=C1)(C)O
|
|
InChI |
InChI=1S/C10H18O/c1-8(2)9-4-6-10(3,11)7-5-9/h4,6,8-9,11H,5,7H2,1-3H3/t9-,10+/m0/s1
|
|
InChIKey |
IZXYHAXVIZHGJV-VHSXEESVSA-N
|
|
Synonyms |
(Z)-p-Menth-2-en-1-ol; cis-2-Menthenol; cis-p-menth-2-en-1-ol; cis-2-p-Menthen-1-ol; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethyl)-, cis-; cis-p-Menth-2-ene-1-ol; cis-p-Mentha-2-en-1-ol; cis-para-Menth-2-en-1-ol; p-Menth-2-en-1-ol, cis; cis-para-Menth-2-ene-1-ol; Menth-2-en-1-ol (cis-p); Menth-2-en-1-ol, cis-para; (Z)-p-Mentha-2-en-1-ol; SCHEMBL8919384; (1R,4R)-4-Isopropyl-1-methylcyclohex-2-enol; 4-Isopropyl-1-methyl-2-cyclohexen-1-ol, cis-; 1-Methyl-4alpha-isopropyl-2-cyclohexen-1alpha-ol; cis-2-Cyclohexene-1-ol-1-methyl-4(1-methylethyl); Q67880197
|
|
CAS | NA | |
PubChem CID | 13918681 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 154.25 | ALogp: | 2.3 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 1 |
Heavy Atoms: | 11 | QED Weighted: | 0.575 |
Caco-2 Permeability: | -4.118 | MDCK Permeability: | 0.00003050 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.401 |
Blood-Brain-Barrier Penetration (BBB): | 0.948 | Plasma Protein Binding (PPB): | 66.05% |
Volume Distribution (VD): | 1.296 | Fu: | 32.18% |
CYP1A2-inhibitor: | 0.174 | CYP1A2-substrate: | 0.655 |
CYP2C19-inhibitor: | 0.097 | CYP2C19-substrate: | 0.834 |
CYP2C9-inhibitor: | 0.056 | CYP2C9-substrate: | 0.092 |
CYP2D6-inhibitor: | 0.01 | CYP2D6-substrate: | 0.087 |
CYP3A4-inhibitor: | 0.688 | CYP3A4-substrate: | 0.527 |
Clearance (CL): | 11.665 | Half-life (T1/2): | 0.441 |
hERG Blockers: | 0.019 | Human Hepatotoxicity (H-HT): | 0.045 |
Drug-inuced Liver Injury (DILI): | 0.035 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.438 | Maximum Recommended Daily Dose: | 0.053 |
Skin Sensitization: | 0.174 | Carcinogencity: | 0.436 |
Eye Corrosion: | 0.956 | Eye Irritation: | 0.957 |
Respiratory Toxicity: | 0.118 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000872 | 1.000 | D04CSZ | 0.261 | ||||
ENC000852 | 0.487 | D07QKN | 0.245 | ||||
ENC000383 | 0.400 | D0H1QY | 0.208 | ||||
ENC001292 | 0.349 | D0K7LU | 0.200 | ||||
ENC004915 | 0.348 | D01CKY | 0.195 | ||||
ENC003266 | 0.348 | D05GKD | 0.188 | ||||
ENC000196 | 0.333 | D06GIP | 0.184 | ||||
ENC002065 | 0.333 | D08KVZ | 0.176 | ||||
ENC002232 | 0.318 | D0P0HT | 0.174 | ||||
ENC000653 | 0.318 | D0V8HA | 0.173 |